Rajiv Kumar1, Nomeeta Gupta. 1. Department of Pediatrics, Batra Hospital & Medical Research Centre, New Delhi, India. drrajivkumar@hotmail.com
Abstract
OBJECTIVE: To study the epidemiological pattern, clinical picture, the recent trends of multidrug-resistant typhoid fever (MDRTF), and therapeutic response of ofloxacin and ceftriaxone in MDRTF. METHODS: The present prospective randomized controlled parallel study was conducted on 93 blood culture-proven Salmonella typhi children. All MDRTF cases were randomized to treatment with ofloxacin or ceftriaxone. RESULTS: Of 93 children, 62 (66.6%) were MDRTF. 24 cases were below 5 years, 26 between 5-10 years and 12 were above 10 years. Male to female ratio was 1.85: 1. Majority of cases came from lower middle socio-economic classes with poor personal hygiene. Fever was the main presenting symptom. Hepatomegaly and splenomegaly was present in 88% and 46% cases respectively. 19 (30.6%) cases developed complications. Mean defervescence time with ceftriaxone and ofloxacin was 4.258 and 4.968 days respectively. CONCLUSION: MDRTF is still emerging as serious public and therapeutic challenge. Ceftriaxone is well-tolerated and effective drug but expensive whereas ofloxacin is safe, cost-effective and therapeutic alternative in treatment of MDRTF in children with comparable efficacy to ceftriaxone.
OBJECTIVE: To study the epidemiological pattern, clinical picture, the recent trends of multidrug-resistant typhoid fever (MDRTF), and therapeutic response of ofloxacin and ceftriaxone in MDRTF. METHODS: The present prospective randomized controlled parallel study was conducted on 93 blood culture-proven Salmonella typhi children. All MDRTF cases were randomized to treatment with ofloxacin or ceftriaxone. RESULTS: Of 93 children, 62 (66.6%) were MDRTF. 24 cases were below 5 years, 26 between 5-10 years and 12 were above 10 years. Male to female ratio was 1.85: 1. Majority of cases came from lower middle socio-economic classes with poor personal hygiene. Fever was the main presenting symptom. Hepatomegaly and splenomegaly was present in 88% and 46% cases respectively. 19 (30.6%) cases developed complications. Mean defervescence time with ceftriaxone and ofloxacin was 4.258 and 4.968 days respectively. CONCLUSION: MDRTF is still emerging as serious public and therapeutic challenge. Ceftriaxone is well-tolerated and effective drug but expensive whereas ofloxacin is safe, cost-effective and therapeutic alternative in treatment of MDRTF in children with comparable efficacy to ceftriaxone.
Authors: A Sinha; S Sazawal; R Kumar; S Sood; V P Reddaiah; B Singh; M Rao; A Naficy; J D Clemens; M K Bhan Journal: Lancet Date: 1999-08-28 Impact factor: 79.321
Authors: M O Wasfy; B A Oyofo; J C David; T F Ismail; A M el-Gendy; Z S Mohran; Y Sultan; L F Peruski Journal: J Health Popul Nutr Date: 2000-06 Impact factor: 2.000
Authors: M D Smith; N M Duong; N T Hoa; J Wain; H D Ha; T S Diep; N P Day; T T Hien; N J White Journal: Antimicrob Agents Chemother Date: 1994-08 Impact factor: 5.191
Authors: Ashwini Kumar; Vinay Pandit; Seema Shetty; Chythra R Rao; Sanjay Pattanshetty; Charmaine M Samarasinghe Journal: Indian J Community Med Date: 2012-10
Authors: Nirmal K Ganguly; N K Arora; Sujith J Chandy; Mohamed Nadeem Fairoze; J P S Gill; Usha Gupta; Shah Hossain; Sadhna Joglekar; P C Joshi; Manish Kakkar; Anita Kotwani; Ashok Rattan; H Sudarshan; Kurien Thomas; Chand Wattal; Alice Easton; Ramanan Laxminarayan Journal: Indian J Med Res Date: 2011-09 Impact factor: 2.375
Authors: R Thamizhmani; Debdutta Bhattacharya; D S Sayi; Haimanti Bhattacharjee; N Muruganandam; S R Ghosal; A P Bharadwaj; M Singhania; Subarna Roy; A P Sugunan Journal: Indian J Med Res Date: 2012-07 Impact factor: 2.375